Evidence map›Paper›PMID 42079156›Full record

ArticlebioRxiv : the preprint server for biology2026

Synovial transcriptional clusters link cartilage degeneration to cell-type-specific gene expression in knee osteoarthritis.

Michael R Mazzucco, Bella Mehta, Jenelys Ruiz-Ortiz, Caryn Hale, Fuadur Omi, Purva Singh, Ruoxi Yuan, Samantha Lessard, Eun Kyung Song, Mengrui Zhang and 18 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Michael R MazzuccoHospital for Special Surgery, New York, NY, USA.ORCID 0000-0001-8443-7936
Bella MehtaHospital for Special Surgery, New York, NY, USA.
Jenelys Ruiz-OrtizThe Rockefeller University, New York, NY, USA.
Caryn HaleThe Rockefeller University, New York, NY, USA.
Fuadur OmiThe Rockefeller University, New York, NY, USA.
Purva SinghHospital for Special Surgery, New York, NY, USA.
Ruoxi YuanHospital for Special Surgery, New York, NY, USA.
Samantha LessardHospital for Special Surgery, New York, NY, USA.
Eun Kyung SongDivision of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Mengrui ZhangDivision of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Shady YounisDivision of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
William H RobinsonDivision of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Daniel RamirezHospital for Special Surgery, New York, NY, USA.
Edward DiCarloHospital for Special Surgery, New York, NY, USA.
Wei WangThe Rockefeller University, New York, NY, USA.
Thomas CarrollThe Rockefeller University, New York, NY, USA.
Jose RodriguezHospital for Special Surgery, New York, NY, USA.
Peter SculcoHospital for Special Surgery, New York, NY, USA.
Xiaoshun LiHospital for Special Surgery, New York, NY, USA.
YiYuan WuWeill Cornell Medicine, New York, NY, USA.
Robert B DarnellThe Rockefeller University, New York, NY, USA.
Martin LotzDepartment of Molecular Medicine, Scripps Research, La Jolla, CA, USA.
Rachel E MillerDivision of Rheumatology, Rush University Medical Center, Chicago, IL, USA.
Tristan MaerzUniversity of Michigan, Ann Arbor, MI, USA.
Anne-Marie MalfaitDivision of Rheumatology, Rush University Medical Center, Chicago, IL, USA.
Accelerating Medicines Partnership: RA/SLE Network (AMP RA/SLE), The RE-JOIN Investigators
Miguel OteroHospital for Special Surgery, New York, NY, USA.
Dana E OrangeHospital for Special Surgery, New York, NY, USA.ORCID 0000-0001-9859-7199

Funding

Disparities in COVID Disease Severity and Outcomes in New York CityUL1TR002384 · NCATS · WEILL MEDICAL COLL OF CORNELL UNIV · PI JULIANNE L IMPERATO-MCGINLEY · 2017 to 2026
$86.2M
Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational SuccessUL1TR001866 · NCATS · ROCKEFELLER UNIVERSITY · PI COLLER, BARRY, KRUEGER, JAMES G · 2016 to 2025
$40.6M
Precision Mapping of Knee Pain in Osteoarthritis: Understanding differences between pain with activity and restUC2AR082186 · NIAMS · RUSH UNIVERSITY MEDICAL CENTER · PI LOTZ, MARTIN K, MALFAIT, ANNE-MARIE · 2022 to 2025
$11.9M
Osteoarthritis Progression And Sensory Pathway AlterationsR01AR064251 · NIAMS · RUSH UNIVERSITY MEDICAL CENTER · PI MALFAIT, ANNE-MARIE, MILLER, RICHARD J · 2013 to 2025
$7.6M
Pain and synovial pathotypes in AMP AIMUC2AR081025 · NIAMS · UNIVERSITY OF ROCHESTER · PI Jennifer Howitt Anolik, Laura T. Donlin · 2022 to 2026
$7.2M
Weill Cornell/Rockefeller/Sloan Kettering MST ProgramT32GM152349 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI KATHARINE C HSU · 2024 to 2026
$6.6M
Molecular Pathways of Pain Generation in OsteoarthritisR01AR060364 · NIAMS · RUSH UNIVERSITY MEDICAL CENTER · PI MALFAIT, ANNE-MARIE · 2011 to 2025
$6.0M
Neurobiology Core CP30AR079206 · NIAMS · RUSH UNIVERSITY MEDICAL CENTER · PI Anne-Marie Malfait · 2021 to 2026
$4.7M
Investigating Mucosal Breaks in the Initiation and Progression of Rheumatoid ArthritisR01AR078268 · NIAMS · STANFORD UNIVERSITY · PI ORANGE, DANA ELIZABETH, ROBINSON, WILLIAM H · 2021 to 2025
$3.1M
Deconstructing Disparities in Lupus PregnanciesK23AR082991 · NIAMS · HOSPITAL FOR SPECIAL SURGERY · PI Bella Mehta · 2024 to 2026
$528k
NCATS NIH HHS UL1 TR001866NCATS NIH HHS UL1 TR002384NIAMS NIH HHS K23 AR082991NIAMS NIH HHS P30 AR079206NIAMS NIH HHS R01 AR060364NIAMS NIH HHS R01 AR064251NIAMS NIH HHS R01 AR078268NIAMS NIH HHS UC2 AR081025NIAMS NIH HHS UC2 AR082186NIGMS NIH HHS T32 GM152349
6 · The paper itself

Abstract

Objectives: To identify synovial transcriptional clusters in human knee osteoarthritis (OA) and determine how these relate to synovial histologic features, cell-type-associated gene expression, and cartilage degeneration severity. Methods: Bulk RNA sequencing (RNA-seq) of synovial tissue from n = 135 patients with knee OA was analyzed using consensus clustering. Clusters were compared by clinical and histologic features, including cartilage degeneration severity (OARSI score). Single-cell RNA-seq (n = 18) and spatial transcriptomics were used to relate cartilage degeneration-associated gene expression patterns to synovial cell populations. Results: Four synovial transcriptional clusters that differed in synovial histologic features and cartilage degeneration severity were identified. Greater cartilage degeneration was associated with enrichment of lining fibroblast- and inflammatory myeloid-associated gene expression, whereas lesser cartilage degeneration was associated with enrichment of sublining fibroblast, endothelial, mural cell, and adipocyte-associated gene expression. Conclusions: Human knee OA synovium segregates into transcriptional clusters associated with cartilage degeneration severity. Synovial transcriptional heterogeneity corresponds to cell-type-associated gene expression.

Identifiers

PMID42079156
PMCPMC13131639

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.